High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To describe the rate of clinically significant rebleeding during 72 hours continuous i.v.
infusion of high dose esomeprazole Na in patients in China with primary successful endoscopic
haemostatic therapy of a bleeding peptic ulcer, with cimetidine i.v. in